you are here: Home News Ozempic

Ozempic

Novo Nordisk slashes Ozempic, Wegovy prices in India, to fend generic competition
Indian founder in UK says Ozempic helped lose 30kg in 8 months, but 'at a cost’. Lists side effects
Eris Lifesciences, Natco Pharma to launch generic Ozempic at 90% cheaper price
Ozempic copies at Rs 1,290 in India as generic GLP-1 era starts
US women inject fat from dead bodies to get hourglass figure: 'It’s like we’re recycling'
'Fatter than ever': Why did Trump mock a wealthy friend to make a point about US drug prices?
Novo Nordisk gears up for December Ozempic launch in India: Report
Ozempic 2.0: How new GLP-1 weight loss pills and monthly shots could transform obesity treatment
Americans are microdosing obesity drugs, driven by 'thin is in' marketing blitz
Sun Pharma Q2 steady — Should investors pop the stock pill?
Ozempic-style medicines could help curb drinking and drug use, scientists hint at bold future
Weight loss drug Ozempic launch in India: Is it safe for diabetes patients? Does it control blood sugar?
India bulk drug makers start preparing for Ozempic patent expiry
Ozempic weight loss might cost you muscle strength, says new study
Green Coffee for Weight Loss? Indian Cricketer Sarfaraz Khan’s 17-kilo drop sparks buzz
Ozempic side effect: Male users reveal change to their genitals after injection
Mounjaro side effects revealed: Decreased appetite, mild nausea and more
Is Ozempic beneficial for you? Nutritionist explains how it can diminish your natural glow
Global pharma giants Eli Lilly, Novo Nordisk launch obesity awareness campaigns, exploring India market potential
Ozempic: A miracle weight-loss drug or dangerous trend? We examine
Trump Tariff – How much can it hurt Indian pharma?
Divis Lab: GLP-1 opportunity to unfold in the medium term
Does Ozempic help in weight loss? Control blood sugar level, reduce hunger to stick to your fitness goals
World Street | EU regulators probe Apple; Canada considers tariffs on China-made EVs; Nvidia stock tumbles; Shein files for London IPO, and more
How a pharma company is helping transform health of Denmark's economy

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Ozempic

Novo Nordisk slashes Ozempic, Wegovy prices in India, to fend generic competition

Indian founder in UK says Ozempic helped lose 30kg in 8 months, but 'at a cost’. Lists side effects

Eris Lifesciences, Natco Pharma to launch generic Ozempic at 90% cheaper price

Ozempic copies at Rs 1,290 in India as generic GLP-1 era starts

US women inject fat from dead bodies to get hourglass figure: 'It’s like we’re recycling'

'Fatter than ever': Why did Trump mock a wealthy friend to make a point about US drug prices?

Novo Nordisk gears up for December Ozempic launch in India: Report

Ozempic 2.0: How new GLP-1 weight loss pills and monthly shots could transform obesity treatment

Americans are microdosing obesity drugs, driven by 'thin is in' marketing blitz

Sun Pharma Q2 steady — Should investors pop the stock pill?

Ozempic-style medicines could help curb drinking and drug use, scientists hint at bold future

Weight loss drug Ozempic launch in India: Is it safe for diabetes patients? Does it control blood sugar?

India bulk drug makers start preparing for Ozempic patent expiry

Ozempic weight loss might cost you muscle strength, says new study

Green Coffee for Weight Loss? Indian Cricketer Sarfaraz Khan’s 17-kilo drop sparks buzz

Ozempic side effect: Male users reveal change to their genitals after injection

Mounjaro side effects revealed: Decreased appetite, mild nausea and more

Is Ozempic beneficial for you? Nutritionist explains how it can diminish your natural glow

Global pharma giants Eli Lilly, Novo Nordisk launch obesity awareness campaigns, exploring India market potential

Ozempic: A miracle weight-loss drug or dangerous trend? We examine

Trump Tariff – How much can it hurt Indian pharma?

Divis Lab: GLP-1 opportunity to unfold in the medium term

Does Ozempic help in weight loss? Control blood sugar level, reduce hunger to stick to your fitness goals

World Street | EU regulators probe Apple; Canada considers tariffs on China-made EVs; Nvidia stock tumbles; Shein files for London IPO, and more

How a pharma company is helping transform health of Denmark's economy